dyphylline (Discontinued)

Brand and Other Names:Dilor (DSC), Lufyllin (DSC)

Dosing & Uses

AdultPediatric

Dosage Forms & Strengths

tablet

  • 200mg
  • 400mg

Asthma/Reversible Bronchospasm

Up to 15 mg/kg PO q6hr PRN  

Reduce in renal impairment

Renal Impairment

CrCl >50 mL/min: Administer 75% of normal dose

CrCl 10-50 mL/min: Administer 50% of normal dose

CrCl < 10 mL/min: Administer 25% of normal dose

Hepatic Impairment

Not studied

Safety & efficacy not established

Next:

Interactions

Interaction Checker

and dyphylline

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 

            Contraindicated (0)

              Serious - Use Alternative (1)

              • levoketoconazole

                levoketoconazole will increase the level or effect of dyphylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.

              Monitor Closely (1)

              • hydrocortisone

                hydrocortisone will decrease the level or effect of dyphylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

              Minor (0)

                Previous
                Next:

                Adverse Effects

                Frequency Not Defined

                Mild & infrequent

                Headache

                Nausea

                Circulatory failure

                Irritability

                Ventricular arrhythmia

                Hypotension

                Tachycardia

                Hyperglycemia

                Muscle twitching

                Albuminuria

                Diuresis

                Hematuria

                Tachypnea

                Restlessness

                Seizure

                Palpitation

                Extrasystoles

                Insomnia

                Upset stomach

                Previous
                Next:

                Warnings

                Contraindications

                Hypersensitivity to dyphylline or other xanthines

                Cautions

                Use caution in severe cardiac disease, HTN, hyperthyroidism, acute myocardial injury, peptic ulcer disease, renal impairment

                Not for status asthmaticus

                Previous
                Next:

                Pregnancy & Lactation

                Pregnancy Category: C

                Lactation: Excreted in breast milk; use with caution

                Pregnancy Categories

                A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

                B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

                C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

                D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

                X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

                NA: Information not available.

                Previous
                Next:

                Pharmacology

                Mechanism of Action

                Bronchodilator; also exhibits peripheral vasodilatory and bronchial smooth muscle relaxant activity

                Pharmacokinetics

                Peak plasma time: 45 min

                Peak plasma:concentration: 1 g dose: 17 mcg/mL

                Half-Life: 2 hr

                Absorption: Rapid

                Metabolism: not metabolized

                Excretion: Urine (88%)

                Previous
                Next:

                Images

                No images available for this drug.
                Previous
                Next:

                Patient Handout

                A Patient Handout is not currently available for this monograph.
                Previous
                Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.